01:42 PM EDT, 09/12/2024 (MT Newswires) -- BioNexus Gene Lab ( BGLC ) plans to partner with Chenzhen Rongguang Health Group to expand cancer screening and diagnostic tools in Southeast Asia and China.

The collaboration includes research and development of exosome therapy and regenerative medicine, BioNexus said Thursday in a statement.

Price: 0.49, Change: +0.14, Percent Change: +38.78